Wellgistics Health (WGRX) | Financial Analysis & Statements
Wellgistics Health Inc. Micro-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.7M
Gross Profit
-7.9M
-470.23%
Operating Income
-12.8M
-766.04%
Net Income
-27.9M
-1,667.19%
Balance Sheet Metrics
Total Assets
30.5M
Total Liabilities
42.9M
Shareholders Equity
-12.4M
Cash Flow Metrics
Operating Cash Flow
-29.6M
Free Cash Flow
-6.5M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Wellgistics Health Income Statement From 2022 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 23.3M | 18.1M | 34.4M | 32.8M |
| Cost of Goods Sold | 29.8M | 16.4M | 31.6M | 27.0M |
| Gross Profit | -6.4M | 1.8M | 2.8M | 5.7M |
| Gross Margin % | -27.5% | 9.7% | 8.1% | 17.5% |
| Operating Expenses | ||||
| Research & Development | - | - | 375 | 1.4K |
| Selling, General & Administrative | 71.6M | 6.8M | 10.1M | 7.1M |
| Other Operating Expenses | - | - | - | - |
| Total Operating Expenses | 71.6M | 6.8M | 10.1M | 7.1M |
| Operating Income | -81.2M | -6.1M | -12.1M | -3.4M |
| Operating Margin % | -347.9% | -33.9% | -35.3% | -10.4% |
| Non-Operating Items | ||||
| Interest Income | - | - | - | - |
| Interest Expense | 4.6M | 831.5K | 1.6M | 287.2K |
| Other Non-Operating Income | -15.5M | 120.4K | 98.1K | 966.1K |
| Pre-tax Income | -101.3M | -6.9M | -13.6M | -2.7M |
| Income Tax | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -101.3M | -6.9M | -13.6M | -2.7M |
| Net Margin % | -433.9% | -37.8% | -39.6% | -8.4% |
| Key Metrics | ||||
| EBITDA | -77.9M | -4.9M | -7.2M | -2.2M |
| EPS (Basic) | - | $-0.15 | $-0.30 | $-0.06 |
| EPS (Diluted) | - | $-0.15 | $-0.30 | $-0.06 |
| Basic Shares Outstanding | - | 47252081 | 44720000 | 46714665 |
| Diluted Shares Outstanding | - | 47252081 | 44720000 | 46714665 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Wellgistics Health Balance Sheet From 2022 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Current Assets | ||||
| Cash & Equivalents | 42.6K | 1.0M | 1.4K | 0 |
| Short-term Investments | - | - | - | - |
| Accounts Receivable | 1.1M | 2.7M | - | - |
| Inventory | 1.6M | 9.5M | - | - |
| Other Current Assets | - | 1 | - | - |
| Total Current Assets | 2.8M | 15.2M | 338.4K | 0 |
| Non-Current Assets | ||||
| Property, Plant & Equipment | 1.6M | 2.1M | - | - |
| Goodwill | 40.6M | 54.8M | - | - |
| Intangible Assets | 12.2M | 22.4M | - | - |
| Long-term Investments | - | - | - | - |
| Other Non-Current Assets | - | 1.4M | - | - |
| Total Non-Current Assets | 27.6M | 42.2M | 0 | 0 |
| Total Assets | 30.5M | 57.3M | 338.4K | 0 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payable | 11.7M | 6.3M | 1.0M | 5.2K |
| Short-term Debt | 11.6M | 12.6M | 350.0K | - |
| Current Portion of Long-term Debt | - | - | - | - |
| Other Current Liabilities | - | - | - | - |
| Total Current Liabilities | 29.8M | 38.0M | 3.2M | 5.2K |
| Non-Current Liabilities | ||||
| Long-term Debt | 13.1M | 12.6M | - | - |
| Deferred Tax Liabilities | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - |
| Total Non-Current Liabilities | 13.1M | 12.6M | 0 | 0 |
| Total Liabilities | 42.9M | 50.6M | 3.2M | 5.2K |
| Equity | ||||
| Common Stock | 10.1K | 5.1K | 4.5K | 0 |
| Retained Earnings | -111.0M | -9.8M | -2.9M | -5.2K |
| Treasury Stock | - | - | - | - |
| Other Equity | - | - | - | - |
| Total Shareholders Equity | -12.4M | 6.7M | -2.9M | -5.2K |
| Key Metrics | ||||
| Total Debt | 24.8M | 25.1M | 350.0K | 0 |
| Working Capital | -27.0M | -22.9M | -2.9M | -5.2K |
Balance Sheet Composition
Wellgistics Health Cash Flow Statement From 2022 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | -101.3M | -6.9M | -2.9M | -5.2K |
| Depreciation & Amortization | 3.2M | 1.1M | - | - |
| Stock-Based Compensation | 54.8M | 1.1M | - | - |
| Working Capital Changes | 5.2M | 1.8M | 764.2K | 5.2K |
| Operating Cash Flow | -38.0M | -2.9M | -2.1M | 0 |
| Investing Activities | ||||
| Capital Expenditures | - | - | - | - |
| Acquisitions | 0 | 931.4K | - | - |
| Investment Purchases | - | - | - | - |
| Investment Sales | - | - | - | - |
| Investing Cash Flow | 0 | 846.4K | - | - |
| Financing Activities | ||||
| Share Repurchases | - | - | - | - |
| Dividends Paid | - | - | - | - |
| Debt Issuance | 2.6M | 0 | - | - |
| Debt Repayment | -24.7M | -135.8K | - | - |
| Financing Cash Flow | -15.6M | 1.6M | 350.5K | 0 |
| Free Cash Flow | -11.7M | -1.6M | -349.1K | 0 |
| Net Change in Cash | -53.6M | -400.9K | -1.8M | 0 |
Cash Flow Trend
Wellgistics Health Key Financial Ratios
Valuation Ratios
Price to Sales
0.77
Profitability Ratios
Profit Margin
-27.54%
Operating Margin
-766.04%
Return on Equity
813.59%
Return on Assets
-115.61%
Financial Health
Current Ratio
0.10
Debt to Equity
-1.97
Per Share Data
EPS (TTM)
$-1.43
Book Value per Share
$-0.12
Revenue per Share
$0.33
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| WGRX | 17.3M | - | - | 813.59% | -27.54% | -1.97 |
| Walgreens Boots | 10.4B | 27.10 | 1.44 | -69.58% | -4.07% | 409.88 |
| High Tide | 211.0M | -3.89 | 3.26 | -39.72% | -7.42% | 110.31 |
| PetMed Express | 47.7M | 257.00 | 1.50 | -100.61% | -34.70% | 1.99 |
| Scienture Holdings | 17.0M | 0.56 | 0.24 | -55.65% | 76.80% | 0.03 |
| Hong Kong Pharma | 14.6M | 6.26 | 1.47 | -13.38% | -4.29% | 44.19 |
Financial data is updated regularly. All figures are in the company's reporting currency.





